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Abstract
Rationale: The endurance time (Tend) during constant-workrate cycling exercise (CET) is highly variable in COPD. We
investigated pulmonary and physiological variables that may contribute to these variations in Tend.
Methods: Ninety-two patients with COPD completed a CET performed at 80% of peak workrate capacity (Wpeak). Patients
were divided into tertiles of Tend [Group 1: ,4 min; Group 2: 4–6 min; Group 3: .6 min]. Disease severity (FEV1), aerobic
fitness (Wpeak, peak oxygen consumption [ _ V VO2peak], ventilatory threshold [ _ V VO2VT]), quadriceps strength (MVC), symptom
scores at the end of CET and exercise intensity during CET (heart rate at the end of CET to heart rate at peak incremental
exercise ratio [HRCET/HRpeak]) were analyzed as potential variables influencing Tend.
Results: Wpeak, _ V VO2peak, _ V VO2VT, MVC, leg fatigue at end of CET, and HRCET/HRpeak were lower in group 1 than in group 2 or 3
(p#0.05). _ V VO2VT and leg fatigue at end of CET independently predicted Tend in multiple regression analysis (r=0.50,
p=0.001).
Conclusion: Tend was independently related to the aerobic fitness and to tolerance to leg fatigue at the end of exercise. A
large fraction of the variability in Tend was not explained by the physiological parameters assessed in the present study.
Individualization of exercise intensity during CET should help in reducing variations in Tend among patients with COPD.
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Introduction
Exercise intolerance is a major concern in patients with chronic
obstructive pulmonary disease (COPD) because it is related to
poor prognosis and impaired quality of life [1,2,3]. Constant-
workrate cycling or walking protocols are frequently used to assess
the impact of COPD on functional capacity and the response to
therapy [1]. The ability of these exercise protocols to detect
improvements in exercise tolerance after various interventions
such as bronchodilation [4,5,6,7,8,9] or pulmonary rehabilitation
[10,11] has been demonstrated. One limitation of constant-
workrate exercise tests (CET) is the large variation in endurance
time among subjects, despite the fact these protocols are
performed, by definition, at the same relative workload
[9,12,13]. Since exercise duration during CET is frequently used
as an outcome parameter in COPD clinical trials, the large
interindividual variations in endurance time is highly relevant
because it markedly influences sample size calculation. Also,
because of the hyperbolic nature of the power-duration relation-
ship of a constant workrate exercise test, the magnitude of
improvement in endurance time following a given intervention will
be influenced by its baseline pre-treatment value: the longer the
pre-treatment endurance time, the larger the post-intervention
improvement [14]. This obviously complicates the interpretation
of improvements that are seen after an intervention. Being able to
reduce this interindividual variability in endurance time at baseline
would allow the design of smaller and less costly clinical trials
whose results would also be easier to interpret.
The multifactorial nature of exercise intolerance in COPD may
explain, in part, such variability in endurance time to CET. In a
previous study, higher breathlessness scores were associated with
reductions in endurance time in patients with COPD [15].
However, the potential role of extrapulmonary factors, such as
physical fitness and the ability to tolerate exercise-related
symptoms (e.g., dyspnea and leg discomfort), as contributors to
the variability in endurance time has not been investigated.
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mation or overestimating peak workrate capacity would lead to the
performance of a CET at an intensity not truly representing 80%
of peak capacity.
From a physiological standpoint, the power-duration relation-
ship, characterizing the time for which a given exercise intensity
can be sustained, has been proposed to determine the optimal
workload in endurance tests [14,15]. However, determining this
relationship individually is not clinically practical because it
requires the completion of several exercise tests of various
intensities and durations. We therefore wished to address the
issue of variability in endurance time from a clinical perspective
with the idea that the identification of pulmonary function and
exercise physiology parameters closely linked to endurance time
could eventually be useful to help predict and reduce heteroge-
neity in the duration of CET.
In order to address the issue of variability in endurance time, we
a priori posited the following hypotheses: individual variations in 1)
disease severity, 2) aerobic fitness (peak exercise capacity,
ventilatory threshold) and quadriceps strength, 3) the tolerance
to dyspnea and leg fatigue during exercise, and 4) the actual (as
opposed to estimated) exercise intensity during CET, could all
contribute to influence exercise duration during a constant-
workrate cycling exercise in patients with COPD. In this study,
we tested these hypotheses by evaluating the variations in
endurance time in 92 patients with COPD that performed a
constant-workrate cycling exercise test at 80% of peak exercise
capacity.
Materials and Methods
Patients
Ninety-two consecutive patients with stable COPD that
performed a constant-workrate cycling exercise test (CET) in our
laboratory between December 2001 and December 2004 were
included in this study. Patients with COPD [forced expiratory
volume in 1 s (FEV1) ,80% predicted and FEV1/forced vital
capacity (FVC) ,0.7] had moderate to severe airflow obstruction
[16]. Subjects were excluded of the study if they presented any
medical conditions potentially influencing exercise testing (i.e.,
clinically diagnosed cardiovascular diseases [except hypertension],
beta-blockers therapy, anemia, neurological, other respiratory
disorders than COPD, recent exacerbation [,4 wk]).
Ethics statement
The research protocol was approved by the institutional ethics
committee (Research ethics committee of the Institut universitaire de
cardiologie et de pneumologie de Que ´bec) and a signed informed consent
was obtained from each subject.
Study design
After pulmonary function measurements, all patients performed
a symptom-limited incremental cycle exercise to determine peak
workrate capacity (Wpeak). On a separate day, quadriceps strength
was measured before the performance of a CET at an intensity of
80% Wpeak. To evaluate the degree of muscle fatigue occurring
during CET, the strength of the quadriceps was reassessed after
CET. Spirometry was done before CET to ensure that patients
were in stable condition. Patients were instructed to take their
regular inhalation therapy during the study.
Pulmonary function tests
Standard pulmonary function tests including spirometry, lung
volumes and DLCO were obtained according to previously
described guidelines [17] and related to normal predicted values
from the European Community for Coal and Steel/European
Respiratory Society [18].
Incremental Exercise Test
A symptom-limited progressive exercise test was performed on a
cycloergometer (Quinton Corival 400; A-H Robins, Seattle, WA).
Gas exchanges parameters (oxygen uptake, [ _ V VO2], CO2 excretion
[ _ V VCO2], minute ventilation [ _ V VE]) and heart rate [HR] were
measured monitored by a breath-by-breath exercise circuit (Sensor
Medics, Vmax Legacy, Yorba Linda, CA). After 5 minutes of rest,
the workload was initially set at 10 watts and subsequently
increased at 1-minute intervals by 10-watt increments until the
patient reached a symptom-limited maximum. Wpeak and peak
oxygen consumption ( _ V VO2peak) were used as the index of peak
exercise capacity. The ventilatory threshold was assessed using the
V-Slope method [1] and reported as the _ V VO2at the inflection point
of the _ V VO2/ _ V VCO2 relationship ( _ V VO2VT). Maximum voluntary
ventilation (MVV) was estimated by multiplying FEV1 by 35 [19].
Ventilatory reserve was estimated from the _ V VE/MVV ratio.
Constant-workrate exercise test (CET)
After 2 min of unloaded pedaling, the workrate was set at 80%
Wpeak while patients were pedaling at 60–70 rotations per minute,
up to exhaustion. No encouragement was provided during the tests
to avoid any potential confounding effect on exercise performance
[20]. The exercise test was stopped when the patient was unable to
maintain a pedalling rate of 40 rpm. The endurance time was
defined as the duration of CET excluding the 2-min warm-up
period. Inspiratory capacity (IC) and pulse oxygen saturation
(SpO2) were measured at rest and at the end of exercise.
Quadriceps strength and fatigue
In seventy-six patients, the strength of the quadriceps was
assessed during volitional maximal contraction (MVC) and during
magnetic stimulation of the femoral nerve (quadriceps twitch force
[Twq]) as described by Saey and colleagues [21]. Twq was also
measured 10 min after CET to assess the post-exercise fall in
quadriceps strength. Contractile quadriceps fatigue was defined as
a post-exercise reduction in Twq of more than 15% from the
resting value [21].
Subjective Measures
Dyspnea and perception of leg fatigue were evaluated at end of
incremental exercise and CET, using the modified 10-point Borg
scale [22].
Data analyses
Variables potentially influencing endurance time were grouped
into 4 categories: i) disease severity, ii) aerobic fitness and
quadriceps function, iii) tolerance to exercise dyspnea and leg
fatigue iv) technical factors. These variables are presented in
Table 1.
Disease severity. We speculated that worse airflow limita-
tion, as assessed by FEV1 and hyperinflation (total lung capacity
[TLC], functional residual capacity [FRC], residual volume [RV]
and inspiratory capacity [IC]) would be associated with lower
endurance time.
Aerobic fitness and quadriceps function. We hypothe-
sized that a lower fitness level (Wpeak, _ V VO2peak, _ V VO2at the
ventilatory threshold [ _ V VO2VT]) would be associated with a
reduced endurance time. We lastly speculated that weaker
quadriceps and a large post-exercise fall in TwQ at 10 minutes
Endurance Time Variability in COPD
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This hypothesis was based on the observation that the
susceptibility to muscle fatigue may contribute to exercise
intolerance in COPD [21,23].
Tolerance to dyspnea and leg fatigue. We posited that the
endurance time would be influenced by the tolerance to exercise-
related symptoms. Our hypothesis was that lower dyspnea and leg
fatigue scores at the end of CET, representing poor tolerance to
symptoms,wouldbeassociated witha reduced endurance time.The
rationale for this hypothesis was that fitter individuals usually reach
higher symptom scores during exercise compared to individuals less
accustomed to the uncomfortable sensations of exercise [24].
Technical factors. Wespeculatedthat underestimating Wpeak
would result in CET being performed below the desired intensity
(80% true peak capacity) and, as a result, in a prolonged endurance
time. Peak heart rate (HRpeak), expressed as a percentage of the
predicted value (220-age) [1], _ V VE/MVV and respiratory exchange
ratio were used to characterize the intensity of incremental exercise
test. The actual intensity of CET was evaluated by calculating the
ratio of heart rate at the end of CET to heart rate at peak
incrementalexercise(HRCET/HRpeak)aswellasfromthe _ V VO2CET/
_ V VO2peak ratio and from the _ V VECET/ _ V VEpeak ratio.
Statistical Analyses
Results are reported as mean 6 SD. The normality of the
variables was checked by the Kolmogorov-Smirnoff test. Subjects
were divided into tertiles of endurance time (Group 1: n=32,
endurance time ,4 min; Group 2: n=31, endurance time from 4
to 6 min; Group 3: n=29, endurance time .6 min). The tertile
cut-off points were chosen to reflect the desirable exercise duration
for CET [25] and to balance the number of patients of the 3
groups. Between groups comparisons were assessed using ANOVA
except for gender distribution which was analysed using chi-square
tests. Possible relationships between endurance time during CET
as the dependant variable, and FEV1, FVC, FEV1/FVC, TLC,
FRC, RV, DLco, IC, delta IC from rest to end-exercise, delta
SpO2 from rest to end-exercise, HRpeak,W peak, _ V VO2peak,
_ V VEpeak, _ V VO2VT as well as maximal voluntary contraction (MVC),
the fall in Twq 10 minutes post exercise and dyspnea and leg
fatigue at end of CET as independent variables, were assessed
using Pearson’s correlations. The possibility that a non-parametric
model (Kendall tau rank correlation) would better describe the
data than Pearson correlations was verified. Since the fit was not
improved by the non-parametric model, only the linear model
(Pearson’s correlation) is reported. From the variables correlated to
endurance time with p value ,0.20, we first used general additive
models to search for second and third-degree relations with
endurance time. Secondly, stepwise regression analyses were used
to determine independent predictors of endurance time during
CET. Assumptions of linear regression were validated via linear
relationship, normality and homoscedasticity. Multicollinearity
was also ruled out to ensure validity of our analyses. A p value
,0.05 was set as the statistical significance threshold. The analyses
were performed with SAS version 9.2 (SAS Institute, Cary, NC).
Results
Subgroup characteristics
The subject characteristics are reported in Table 2. No
significant differences were found between groups for age, gender
and body mass index. The range of Tend during CET is provided
in Figure 1. The endurance time of the whole group of patients
averaged 349 s, ranging from 120 to 1164 s.
Table 1. Variables potentially influencing endurance time.
Categories Variables
Disease severity Airflow limitation : FEV1
Hyperinflation : TLC, FRC, RV and IC
Aerobic fitness and
quadriceps function
Fitness :W peak , _ V VO2peak , _ V VO2VT
Quadriceps strength: MVC and Twq
Quadriceps fatigue : fall in Twq after CET
Tolerance to dyspnea
and leg fatigue
Dyspnea and leg fatigue at end of CET
Technical factors Optimality of incremental exercise test:
HRpeak (% predicted value)
_ V VE/MVV
Respiratory exchange ratio
Actual intensity of CET:
HRCET/HRpeak
_ V VO2CET/ _ V VO2peak
_ V VECET/ _ V VEpeak
Definitions of abbreviations: CET: constant-workrate exercise test; HR: heart rate;
_ V VE: minute ventilation; MVV: maximal voluntary ventilation; FEV1: forced
expiratory volume in 1 second; TLC: total lung capacity; FRC: functional residual
capacity; RV: residual volume; IC: inspiratory capacity; _ V VO2: oxygen consumption;
_ V VO2VT: ventilatory threshold; MVC: maximal voluntary contraction.
doi:10.1371/journal.pone.0017007.t001
Table 2. Subject characteristics and pulmonary function.
Variables
Group 1
(n=32)
Tend,4m i n
Group 2
(n=31)
Tend=4–6 min
Group 3
(n=29)
Tend.6m i n
ANOVA
p value
Age, years 68676 5 686 6 67 0.13
Gender, M/F 25/7 24/7 26/3 0.11
BMI, kg/m
2 27.363.8 26.265.3 27.864.0 0.34
FEV1, L 1.1460.42 1.2960.46 1.4260.40 0.54
FEV1, % pred 44614 50618 50614 0.56
FVC, L 2.6160.91 2.6360.77 2.8060.78 0.95
FEV1/FVC, % 44694 9 610 5166 0.11
TLC, L 6.6261.29 6.5761.38 7.4461.07 0.11
TLC, % pred 108614 109615 118617 0.23
FRC, L 4.1860.89 4.4761.28 5.1361.03 0.36
FRC, % pred 123622 135632 148631 0.83
RV, L 3.6461.04 3.4861.20 3.7860 83 0.57
RV, % pred 135638 135647 142636 0.62
DLCO,
mL/mmHg/min
14.564.3 15.866.2 18.864.7 0.06
DLCO, % pred 46.2611.9 52.1618.0 58.6614.3 0.15
IC, L 2.3160.64 2.2660.59 2.3460.65 0.32
IC, % pred 86617 86619 85618 0.39
IC/TLC % 33693 3 693 1 66 0.69
FRC/TLC % 66696 4 615 6669 0.72
RV/TLC % 54695 2 611 5367 0.71
Baseline
SpO2, %
96639 7 629 7 62 0.50
Values are mean 6 SD.
Definitions of abbreviations: BMI: body mass index; FEV1: forced expiratory volume
in 1 s; FVC: forced vital capacity; TLC: total lung capacity; FRC: functional residual
capacity; RV: residual volume; DLCO: single-breath carbon monoxide diffusion
capacity; IC: inspiratory capacity; SpO2: Oxygen pulse saturation.
doi:10.1371/journal.pone.0017007.t002
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Pulmonary function results were similar between the three
groups (Table 2). No difference was found between groups in the
fall in IC from rest to end exercise during CET (Table 3).
Aerobic fitness and quadriceps function
Patients in group 1 had lower aerobic fitness than group 2 and/
or 3 when considering Wpeak, _ V VO2peak (Figure 2a) and _ V VO2VT
(Table 3). MVC was lower in group 1 as compared with group 2
(Figure 2b). Twq (Figure 2b) and the fall in Twq after CET
(Table 3) were not different across the three groups.
Tolerance to dyspnea and leg fatigue
Group mean values for symptom scores at end of CET are
shown on Figure 2c. There were no significant differences between
groups in dyspnea at end of CET. However, leg fatigue scores at
end of CET were lower in group 1 when compared with group 3.
Technical factors
Cardio-respiratory values at the end of incremental exercise and
CET are reported in Table 3. HRpeak expressed in % predicted
value was not significantly different between groups. _ V VE/MVV at
peak incremental exercise was above 100% in the 3 groups.
Respiratory exchange ratio at the end of incremental exercise was
also not different across the three groups. Overall, these results
would suggest that patients of the 3 groups achieved a truly
maximal performance during incremental testing. There was no
significant difference between groups in dyspnea or leg fatigue at
end of incremental exercise suggesting that patients in the three
groups reached symptom limitation.
During constant exercise, HRCET expressed in % of the peak
value (reached during incremental exercise) was significantly lower
in group 1 as compared with group 2 and 3 (Table 3). However,
there was no significant difference in _ V VO2CET and _ V VECET between
the three groups when these parameters were expressed in % peak
value suggesting that the intensity of CET was similar between
groups. Thus, shorter exercise duration in group 1 could not be
explained by greater exercise intensity during CET.
Despite the fact that CET was performed at a fixed proportion
of Wpeak, there was a large interindividual variability in the actual
exercise intensity during CET as assessed by the _ V VO2CET/ _ V VO2peak
ratio (Figure 3).
Predictors of endurance time to CET
Correlation coefficients between independent variables and
Tend are reported in Table 4. FEV1, FEV1/FVC, TLC, DLCO,
IC, Wpeak, _ V VEpeak, _ V VO2 peak, _ V VO2VT and leg fatigue score at the
end of CET were all positively associated with endurance time in
the univariate analysis. From these variables that significantly
correlated with Tend in univariate analyses, only _ V VO2VT and leg
fatigue score at end of CET were independent predictors of
endurance time variability in the stepwise regression analysis. This
model explained only 25% of the variability in endurance time
(cumulative r
2=0.25, p,0.0001).
Discussion
Constant-workrate exercise testing was designed to assess
exercise capacity at a fixed and predefined intensity across
individuals. Herein we report that, in fact, this exercise testing
modality was performed at highly variable relative intensities
Figure 1. Range of endurance time (Tend) during constant-workrate cycling exercise in all patients (n=92). Tend varied from 120 to
1164 s.
doi:10.1371/journal.pone.0017007.g001
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time from one patient to another. The ability to tolerate leg fatigue
during CET and the ventilatory threshold, as a reflection of
aerobic fitness, were independent predictors of the variation in
endurance time to CET. However, the ability of the physiological
variables that were assessed in the present study to collectively
explained the interindividual variability in endurance time to CET
was modest, our regression model explaining only 25% of the
variability in endurance time.
Disease severity
Although we did not observed significant differences between
groups in respiratory parameters, several pulmonary function
indices (FEV1, FEV1/FVC and DLCO) positively correlated with
endurance time (Table 4), suggesting that disease severity was
associated with lower endurance time. These results corroborate to
the well documented relation between ventilation limitation and
exercise tolerance [26]. However, none of the parameters was
independently associated with endurance time in the multiple
regression analysis, suggesting that non-respiratory variables may
be stronger determinants of endurance time variability than
airflow limitation in COPD patients.
Aerobic capacity and quadriceps function
As hypothesized, we found a lower peak exercise capacity
(Figure 2a) and ventilatory threshold (Table 3) in group 1 than in
group 2 and 3, suggesting that lower aerobic fitness was associated
with reduced endurance time in patients with COPD. We also
observed that quadriceps strength (Figure 2b) was lower in group 1
patients, suggesting that reduced quadriceps force was associated
with shorter endurance time. Those variables all positively
correlated with endurance time (Table 4).
Table 3. Cardio-respiratory values at the end of incremental exercise and constant-workrate exercise test.
Variables
Group 1
Tend,4m i n
Group 2
Tend=4–6 min
Group 3
Tend.6m i n
ANOVA
p value
Incremental exercise
Wpeak (Watt) 72633*
{ 92630 99628 0.002
HRpeak (bpm) 130618* 141615 137615 0.03
HRpeak (%pred) 85611 91688 9 610 0.07
_ V VO2peak (L/min) 1.0760.36
{ 1.2460.52 1.4160.46 0.02
_ V VO2peak (%pred) 60617 74634 74622 0.08
_ V VO2VT (L/min) 0.7960.25
{ 0.8860.27 0.9960.34 0.01
RER peak 1.0860.11 1.1360.09 1.1160.08 0.16
_ V VEpeak (L/min) 43.5612.3
{ 50.5616.2 54.3615.3 0.002
_ V VEpeak (% MVV) 101620 107620 108620 0.13
Dyspnea peak 7.162.0 6.662.3 7.762.0 0.15
Leg Fatigue peak 7.062.0 6.962.3 7.562.2 0.64
Constant-workrate exercise test (CET)
HRCET (bpm) 120619*
{ 139614 134616 ,0.0001
HRCET (%peak) 92610*
{ 99689 8 69 0.01
_ V VO2CET (L/min) 0.9660.36
{ 1.1560.34 1.3860.48 0.04
_ V VO2CET (%peak) 94621 99 6 14 98614 0.40
_ V VO2CET/ _ V VO2VT 126627 137623 140629 0.13
_ V VO2CET/ _ V VO2peak 94621 99614 98614 0.41
_ V VECET (L/min) 39611*
{ 48613 54617 0.0006
_ V VECET (%peak) 93610 97689 9 614 0.14
DIC from rest (L) 0.6560.41 0.4760.40 0.4560.41 0.15
DSpO2 from rest (%) 2364 2464 2262 0.18
Dyspnea CET 7.362.2 7.462.1 8.061.9 0.34
Leg Fatigue CET 6.262.5
{ 7.362.0 8.362.1 0.003
Fall in Twq after
CET (% baseline)
17621 22615 19624 0.65
Values are mean 6 SD. Peak values were obtained at the end of incremental exercise. Constant-workrate exercise values were obtained at the end of constant-workrate
exercise.
*p#0.02 versus group 2.
{p#0.03 versus group 3.
Definitions of abbreviations: Wpeak: peak workrate capacity; HR: heart rate; _ V VO2: oxygen consumption; _ V VO2VT: ventilatory threshold; _ V VE: minute ventilation; MVV: maximal
voluntary ventilation; RER: respiratory exchange ratio; CET; constant-workrate exercise test; IC: inspiratory capacity; Twq: Quadriceps twitch tension; SpO2: Oxygen pulse
saturation.
doi:10.1371/journal.pone.0017007.t003
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On average, patients from the 3 groups reached similar peak
effort perception as evidenced by the similar dyspnea and leg
fatigue scores at the end of incremental exercise. However,
patients in group 1 reached a lower leg fatigue score at end of CET
than group 3 (Figure 2c). This is important since this variable
correlated with endurance time during CET (Table 4). Further-
more, subjects from all groups presented similar ventilatory
limitations as highlighted by similar end-CET dyspnea and _ V VE/
MVV levels. Consequently, lower leg fatigue score in group 1
patients may reflect that these individuals were less tolerant to leg
fatigue during exercise. This statement is consistent with the
notion that less fit individuals reach lower symptom scores during
exercise compared to fitter individuals more accustomed to the
uncomfortable sensations of exercise [24].
Technical factors
We evaluated the possibility that an underestimation in peak
workrate capacity may have lead to unduly prolonged CET. The
fact that HRpeak expressed as % predicted value, _ V VEpeak/MVV,
and respiratory exchange ratio at the end of incremental exercise
were not different between the 3 groups indicates that the ability to
reach peak exercise capacity was comparable among them.
Therefore this technical factor could not explain the variability
in endurance time. A _ V VEpeak/MVV ratio .1 and a respiratory
exchange ratio .1.1 in all three groups suggest that incremental
exercise testing was truly maximal [27]. Also, higher exercise
intensity during CET could not be responsible for the shorter
exercise duration in group 1, since _ V VO2CET expressed as % peak
value reached during incremental exercise and _ V VO2CET/ _ V VO2VT
ratio tended to be lower in these patients (Table 3).
Although relative exercise intensity during constant-workrate
exercise was a priori identical in all subjects (80% Wpeak), we
observed a large interindividual variability in _ V VO2CET/ _ V VO2peak
ratio (Figure 3) indicating that selecting exercise intensity based on
a fixed ratio of workload does not result in the same physiological
stress.
We took advantage of this dataset to take a clinical and
pragmatic approach to try to understand the mechanisms
explaining the observed variations in endurance time. One
strength of the present study is that all patients were evaluated
Figure 2. Selected correlates of endurance time. Group mean
values for i) peak workrate (Wpeak) and peak oxygen consumption
( _ V VO2peak) during incremental exercise (panel A); ii) quadriceps strength
assessed during magnetic stimulation of the femoral nerve (Twq) and
maximal voluntary contraction (MVC) (panel B) and iii) symptom scores
at the end of constant-workrate cycling exercise test (CET) (panel C) in
group 1 (Tend,4 min, black bars), group 2 (Tend=4–6 min, bright grey
bars) and group 3 (Tend.6 min, dark grey bars) patients. * p#0.02
versus group 2; { p#0.01 versus group 3.
doi:10.1371/journal.pone.0017007.g002
Figure 3. Actual exercise intensity during constant-workrate
cycling exercise (CET) in all patients (n=92). Data are expressed
as the oxygen consumption at the end of CET to peak oxygen
consumption during incremental exercise ratio ( _ V VO2CET/ _ V VO2peak).
doi:10.1371/journal.pone.0017007.g003
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procedures provided by experienced investigators. The sample
size is relatively large and physiological variables covering
various aspects of exercise physiology were assessed. We
acknowledge that the tercile analysis may have suffered from a
reduced power to detect some relevant differences between the
three categories of endurance time. This potential limitation was
addressed by also performing correlation analyses from the
whole sample size. These two approaches could be viewed as
complementary in the identification of predictors of the
variability in endurance time. We appreciate the retrospective
nature of this study and the fact that investigating the variability
in exercise duration was not the primary reason for the exercise
testing. In this perspective, we could not extend our analysis to
some other physiological (i.e maximal respiratory pressures) and
non-physiological (i.e. anxiety, depression) factors potentially
influencing endurance time in COPD. Finally, giving the
majority of men in our cohort, caution should be taken before
applying the findings to women in COPD.
Importantly, this retrospective study was not designed to
determine how to select CET intensity and homogenize exercise
duration, but to elucidate potential factors responsible for the high
variability in endurance time. Still, one possible approach could be
to use different relative exercise intensities according to disease
severity and aerobic capacity. Whether this approach would be
successful is difficult to predict because only a modest fraction of
the variability in endurance time could be predicted from our
multiple regression model. The clinical message emerging from
this study is that predicting the endurance time during contant-
workrate cycling exercise from clinical and physiological param-
eters is likely to be difficult. A physiological approach based on the
determination of the power-duration relationship is impractical in
the clinical setting. A more realistic method could be to realize a
familiarization constant-workrate cycling exercise test at a given
intensity (e.g. 80%) and, if necessary, to adjust the intensity in
subsequent tests in order to obtain the desire exercise duration
[25].
Conclusion
Although worse pulmonary function was related to short
endurance time, _ V VO2VT and leg fatigue Borg score were the only
independent predictors of endurance time variability in this study.
Yet, taken together, the variables assessed in the present
investigation only accounted for 25% of endurance time variability
during CET, suggesting that a large fraction in endurance time
could not be explained by those physiological parameters. This
study highlights the complex nature of exercise limitation in
COPD. Furthermore, exercise tests performed at a fixed pro-
portion of peak incremental workload capacity do not provide the
same physiological stress among individuals. This approach is
unlikely to result in the optimal 4–7 min duration for CET.
Further studies are needed to learn how to individualize the
exercise intensity during CET in COPD patients.
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